SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-016583
Filing Date
2022-06-08
Accepted
2022-06-08 16:26:43
Documents
15
Period of Report
2022-06-07
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aveo-20220607.htm   iXBRL 8-K 65209
2 EX-3.1 aveopharmaceuticalsinc-d.htm EX-3.1 1438
6 aveopharmaceuticalsinc-d001.jpg GRAPHIC 69594
7 aveopharmaceuticalsinc-d002.jpg GRAPHIC 126872
  Complete submission text file 0001628280-22-016583.txt   477153

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aveo-20220607.xsd EX-101.SCH 1915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aveo-20220607_lab.xml EX-101.LAB 23876
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aveo-20220607_pre.xml EX-101.PRE 12532
9 EXTRACTED XBRL INSTANCE DOCUMENT aveo-20220607_htm.xml XML 11263
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34655 | Film No.: 221003836
SIC: 2834 Pharmaceutical Preparations